Concepedia

Iván Bottoli

IB

6

Publications

170

Citations

6

H-Index

2008

Active since

Affiliations

Novartis (United States)(Current)

Novartis (Switzerland)

Novartis (India)

Imperial College London

Iván Bottoli is an author at Novartis (United States) specializing in urology, anesthesiology, and pharmacotherapy.

Top concepts

Publications per year

2008–2023

6

Publications

6

Ligelizumab treatment for severe asthma: learnings from the clinical development programme

Jordis Trischler, Iván Bottoli, Reinhold Janocha et al. · Clinical & Translational Immunology · 2021 · 42 citations · Full text

Icenticaftor, a CFTR Potentiator, in COPD: A Multicenter, Parallel-Group, Double-Blind Clinical Trial

Fernando J. Martínez, Gerard J. Criner, Margret Jandl et al. · American Journal of Respiratory and Critical Care Medicine · 2023 · 41 citations · Full text

Ligelizumab impairs <scp>IgE</scp>‐binding to plasmacytoid dendritic cells more potently than omalizumab and restores <scp>IFN</scp>‐α production and <scp>FOXP3</scp><sup>+</sup> Treg generation

Cristina Benito‐Villalvilla, Andrés de la Rocha‐Muñoz, Jacobo López‐Abente et al. · Allergy · 2022 · 28 citations · Full text

Tegaserod in patients with mechanical sensitivity and overlapping symptoms of functional heartburn and functional dyspepsia

Philip B. Miner, Sheila Rodriguez-Stanley, Howard M. Proskin et al. · Current Medical Research and Opinion · 2008 · 25 citations

Safety and efficacy of the cystic fibrosis transmembrane conductance regulator potentiator icenticaftor (QBW251)

Shamsah Kazani, David J. Rowlands, Iván Bottoli et al. · Journal of Cystic Fibrosis · 2020 · 24 citations · Full text

Rows per page

1–5 of 6